Employees Retirement System of Texas’s Cytokinetics CYTK Stock Holding History

Employees Retirement System of Texas’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-43,358	Closed	-$1.7M	–	431
2022 Q2	$1.7M	Sell	43,358 -32,000	-42%	-$1.29M	0.02%	537
2022 Q1	$2.77M	Hold	75,358	–	–	0.03%	460
2021 Q4	$3.44M	Hold	75,358	–	–	0.04%	435
2021 Q3	$2.69M	Hold	75,358	–	–	0.03%	501
2021 Q2	$1.49M	Hold	75,358	–	–	0.02%	620
2021 Q1	$1.75M	Hold	75,358	–	–	0.02%	609
2020 Q4	$1.57M	Hold	75,358	–	–	0.02%	533
2020 Q3	$1.63M	Sell	75,358 -14,000	-16%	-$327K	0.02%	537
2020 Q2	$2.11M	Hold	89,358	–	–	0.03%	462
2020 Q1	$1.05M	Hold	89,358	–	–	0.02%	565
2019 Q4	$948K	Hold	89,358	–	–	0.01%	711
2019 Q3	$1.02M	Buy	89,358 +39,358	+79%	+$494K	0.02%	697
2019 Q2	$563K	Hold	50,000	–	–	0.01%	943
2019 Q1	$405K	Hold	50,000	–	–	0.01%	1001
2018 Q4	$316K	Hold	50,000	–	–	0.01%	1012
2018 Q3	$493K	Hold	50,000	–	–	0.01%	997
2018 Q2	$415K	Hold	50,000	–	–	0.01%	1022
2018 Q1	$360K	Buy	+50,000	New	+$429K	﹤0.01%	997

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Employees Retirement System of Texas's CYTK Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Cytokinetics (CYTK) in Q3 2022, closing a stake of 43,358 shares — an estimated $1.7M sold.

Employees Retirement System of Texas first reported a position in CYTK in Q1 2018 and held it in 18 quarters. The position peaked at $3.44M in Q4 2021. 277 funds tracked by Wall St. Rank hold CYTK as of Q3 2022.

Employees Retirement System of Texas reported no remaining Cytokinetics position as of Q3 2022 after selling out during the quarter.
Employees Retirement System of Texas sold 43,358 Cytokinetics shares in Q3 2022, an estimated $1.7M.
Employees Retirement System of Texas first reported a position in Cytokinetics in Q1 2018 and held it in 18 quarters.
Employees Retirement System of Texas's Cytokinetics position peaked at $3.44M in Q4 2021.
277 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.